GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » Additional Paid-In Capital

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Additional Paid-In Capital : $11.35 Mil(As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories Additional Paid-In Capital?


Kraig Biocraft Laboratories's quarterly additional paid-in capital increased from Jun. 2023 ($10.89 Mil) to Sep. 2023 ($10.96 Mil) and increased from Sep. 2023 ($10.96 Mil) to Dec. 2023 ($11.35 Mil).

Kraig Biocraft Laboratories's annual additional paid-in capital increased from Dec. 2021 ($9.89 Mil) to Dec. 2022 ($10.84 Mil) and increased from Dec. 2022 ($10.84 Mil) to Dec. 2023 ($11.35 Mil).


Kraig Biocraft Laboratories Additional Paid-In Capital Historical Data

The historical data trend for Kraig Biocraft Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories Additional Paid-In Capital Chart

Kraig Biocraft Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.41 5.83 9.89 10.84 11.35

Kraig Biocraft Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.84 10.79 10.89 10.96 11.35

Kraig Biocraft Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Kraig Biocraft Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.
Executives
Jonathan Richard Rice officer: COO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson director, 10 percent owner, officer: CEO, CFO 2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Headlines

From GuruFocus